Journal of Cardiovascular Pharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.5 | Q2 | 53.6% | 0.676 | Q2 | 71.8% |
| 2024 | 2.2 | Q2 | 52.2% | 0.684 | Q2 | 72.8% |
| 2023 | 2.6 | Q2 | 52.4% | 0.610 | Q2 | 71.5% |
| 2022 | 3.0 | Q3 | 53.3% | 0.641 | Q2 | 74.1% |
| 2021 | 3.3 | Q3 | 54.7% | 0.694 | Q2 | 77.2% |
| 2020 | — | — | 0.762 | Q2 | 78.5% | |
| 2019 | — | — | 0.800 | Q2 | 80.4% | |
| 2018 | — | — | 0.837 | Q2 | 79.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0160-2446
ISSN
1533-4023
country
UScoverage
1979-2026